SCHEMBL4083379

SCHEMBL4083379

Cc1ccc2c(c1)c(C(=O)C(=O)Nc1ccnc(C)c1)c(C(F)(F)F)n2Cc1ccc(Cl)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.53
SMARCA2 P51531 1/20 0.37
SMARCA4 P51532 1/20 0.37
NR2E1 Q9Y466 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
MAPK1 P28482 1/20 0.36
TP53 P04637 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
JAK2 O60674 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
EPHX2 P34913 1/20 0.35
SORT1 Q99523 2/20 0.34
USP2 O75604 1/20 0.33
P2RX7 Q99572 1/20 0.33
THRB P10828 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4384201 0.99 FAAH (0.53) FAAHSMARCA2SMARCA4NR2E1PTGS1
SCHEMBL4100722 0.96 FAAH (0.47) FAAHSMARCA2SMARCA4NR2E1MAPK1
SCHEMBL3004476 0.94 FAAH (0.53) FAAHSMARCA2SMARCA4NR2E1PTGS1
SCHEMBL4088941 0.93 FAAH (0.45) FAAHSMARCA2SMARCA4NR2E1MAPK1
SCHEMBL4089223 0.91 FAAH (0.43) FAAHSMARCA2SMARCA4NR2E1SMN1; SMN2
SCHEMBL3004382 0.91 FAAH (0.49) FAAHNR2E1TP53SMN1; SMN2JAK2
SCHEMBL4101968 0.91 FAAH (0.49) FAAHPTGS1PTGDR2MAPK1SMN1; SMN2
SCHEMBL4089355 0.90 FAAH (0.65) FAAHSMARCA2SMARCA4TP53SMN1; SMN2
SCHEMBL4100773 0.90 FAAH (0.45) FAAHSMARCA2SMARCA4NR2E1MAPK1
SCHEMBL3005756 0.89 FAAH (0.57) FAAHSMARCA2SMARCA4PTGS1PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
CN-102850324-A Indole compounds MICROBIA INC 2013-01-02 CN disclosed
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 FAAH 1/4885SMARCA2 3375/4885SMARCA4 3200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.